The global cold disposable biopsy forceps market is expected to achieve a valuation of USD 634.6 million in 2023, with ...

Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of SHORTEN-ctDNA, a clinical trial at Columbia University.1 The study ...

SOLVE FSHD, a venture philanthropy organization dedicated to catalyzing innovation and overcoming barriers to accelerate new therapies for facioscapulohumeral muscular dystrophy (FSHD), is calling on ...

The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...

Tracking North Atlantic right whales is a team effort spanning the entire U.S. Atlantic coast from Canada to Florida.

“For instance, replacing solid support columns with a honeycomb structure can achieve the same strength with less material ... One focus area is developing technology for cancer detection through ...

A single DMR was combined with GLP-1RA administration to achieve discontinuation of insulin treatment ... This could be due to the small tissue amount that can be collected through an endoscopic ...

NEWARK, Del, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global biopsy device market is on track for steady growth over the next decade, with a projected valuation of USD 2,274.1 million in 2024 ...

NEWARK, Del, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The global biopsy device market is on track for steady growth over the next decade, with a projected valuation of USD 2,274.1 million in 2024, according ...